These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 709910)

  • 1. Correlation between hypersensitivity to parenteral chymopapain and the presence of IgE anti-chymopapain antibody.
    Kapsalis AA; Stern IJ; Bornstein I
    Clin Exp Immunol; 1978 Jul; 33(1):150-8. PubMed ID: 709910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment serum levels of IgE to chymopapain in reactive patients.
    Sagona MA; Bruszer G; Pearson F; Mascoli CC; Serkes K
    Ann Allergy; 1985 Nov; 55(5):674-7. PubMed ID: 4061973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic methods of study for evaluating the risk of anaphylactic reactions in intradisk chymopapain injections].
    Nitzschke E; Wahn U; Schleberger R
    Neurochirurgia (Stuttg); 1986 Sep; 29 Suppl 1():156-60. PubMed ID: 2431331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preoperative chymopapain sensitivity test for chemonucleolysis candidates.
    Tsay YG; Jones R; Calenoff E; Sun J; Arndt L; Crispin B; Rock H
    Spine (Phila Pa 1976); 1984 Oct; 9(7):764-8. PubMed ID: 6390722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chymopapain allergy: case reports and identification of patients at risk for chymopapain anaphylaxis.
    Grammer LC; Ricketti AJ; Schafer MF; Patterson R
    Clin Orthop Relat Res; 1984 Sep; (188):139-43. PubMed ID: 6380859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of IgE and IgG serum levels to chymopapain after chemonucleolysis.
    Sagona MA; Bruszer GV; Nelson JC; Mascoli C; Serkes K
    J Allergy Clin Immunol; 1985 Jun; 75(6):659-62. PubMed ID: 3891823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chymopapain allergy. Diagnostic value of a skin test before and after chemonucleolysis].
    Mayer HM; Brock M
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):51-6. PubMed ID: 3887196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and prevention of allergic reactions following chemonucleolysis with chymopapain].
    Mayer HM
    Neurochirurgia (Stuttg); 1986 Sep; 29 Suppl 1():149-53. PubMed ID: 3491335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity testing with the Chymo-FAST test.
    Hewitt BE
    Neurochirurgia (Stuttg); 1986 Sep; 29 Suppl 1():154-5. PubMed ID: 3537821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anesthesiologic aspects of chemonucleolysis in local anesthesia].
    Schäffer J; Piepenbrock S; Mayer HM; Brock M
    Anasth Intensivther Notfallmed; 1985 Apr; 20(2):62-4. PubMed ID: 2990249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Cogen F; Dolovich J; Schatz M; Zeiger R; Shaughnessy JJ; Gutt L
    Clin Orthop Relat Res; 1988 Sep; (234):12-5. PubMed ID: 3409565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chymopapain-induced hypersensitivity following chemonucleolysis.
    Tsay YG; Jones R; Calenoff E; Sun J; Arndt L; Crispin B; McDermott D; Stern I
    Spine (Phila Pa 1976); 1984 Oct; 9(7):769-71. PubMed ID: 6390723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis.
    Bernstein DI; Gallagher JS; Ulmer A; Bernstein IL
    J Allergy Clin Immunol; 1985 Sep; 76(3):458-65. PubMed ID: 3897344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitization to chymopapain in patients treated with chemonucleolysis].
    García-Ortega P; Ramírez Ferreiras W; Sancho A; Urías S; Cisteró A
    Med Clin (Barc); 1991 Mar; 96(11):410-2. PubMed ID: 2046428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemonucleolysis. The treatment of lumbar intervertebral disc disease by the intradiscal injection of chymopapain.
    Watts C; Gaines R
    Mo Med; 1983 Dec; 80(12):735-7, 742. PubMed ID: 6371477
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Dolovich J; Schatz M; Zeiger R; Cogen F; Shaughnessy JJ; Chandler MJ
    Clin Orthop Relat Res; 1987 Aug; (221):202-6. PubMed ID: 3608299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymodiactin postmarketing surveillance. Demographic and adverse experience data in 29,075 patients.
    Agre K; Wilson RR; Brim M; McDermott DJ
    Spine (Phila Pa 1976); 1984; 9(5):479-85. PubMed ID: 6387953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemonucleolysis of prolapsed lumbar intervertebral discs.
    McManus F
    Ir Med J; 1982 Jul; 75(7):234-5. PubMed ID: 6752096
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on chymopapain.
    Shields CB; Arpin EJ
    Neurol Clin; 1985 May; 3(2):393-403. PubMed ID: 3894923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin E antibodies to papaya proteinases and their relevance to chemonucleolysis.
    Dando PM; Sharp SL; Buttle DJ; Barrett AJ
    Spine (Phila Pa 1976); 1995 May; 20(9):981-5. PubMed ID: 7631245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.